HATO Medical Technologies empowers healthcare professionals to make prompt decisions, accurate triage, correct referrals, and save lives and valuable resources by getting it right the first time. The company utilises artificial intelligence to enhance the accuracy and efficiency of electrocardiogram (ECG) interpretation. By providing innovative solutions, HATO aims to support healthcare professionals, especially those without specialised cardiology expertise, in diagnosing and treating cardiovascular diseases more effectively.

 

    • Founding year:
2020

    • Development phase:
Beta-testing

    • Funding stage:
Pre-seed

    • Website:

    • Contact person info:
sy(at)hatomedicaltechnologies.com

    • Team members:
6